| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | TSP50 |
| Uniprot No | Q9UI38 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-385 aa |
| 活性数据 | MGRWCQTVARGQRPRTSAPSRAGALLLLLLLLRSAGCWGAGEAPGALSTADPADQSVQCVPKATCPSSRPRLLWQTPTTQTLPSTTMETQFPVSEGKVDPYRSCGFSYEQDPTLRDPEAVARRWPWMVSVRANGTHICAGTIIASQWVLTVAHCLIWRDVIYSVRVGSPWIDQMTQTASDVPVLQVIMHSRYRAQRFWSWVGQANDIGLLKLKQELKYSNYVRPICLPGTDYVLKDHSRCTVTGWGLSKADGMWPQFRTIQEKEVIILNNKECDNFYHNFTKIPTLVQIIKSQMMCAEDTHREKFCYELTGEPLVCSMEGTWYLVGLVSWGAGCQKSEAPPIYLQVSSYQHWIWDCLNGQALALPAPSRTLLLALPLPLSLLAAL |
| 分子量 | 67.98 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人TSP50蛋白的参考文献及其摘要内容的简要列举(注：文献信息为基于领域知识的合理示例，部分可能为虚构内容，建议通过学术数据库核实)：
---
1. **文献名称**：*Recombinant Expression and Functional Characterization of Human Testisin (TSP50) in Cancer Cell Invasion*
**作者**：Zhang, Y. et al. (2018)
**摘要**：本研究通过大肠杆菌系统成功表达并纯化重组人TSP50蛋白，验证其丝氨酸蛋白酶活性。实验表明，TSP50通过降解细胞外基质蛋白(如纤维连接蛋白)促进卵巢癌细胞侵袭，其活性可被特异性抑制剂阻断，提示其作为癌症治疗的潜在靶点。
2. **文献名称**：*TSP50 Promotes Tumor Angiogenesis via Protease-Activated Receptor 2 (PAR2) Signaling Pathway*
**作者**：Chen, L. et al. (2020)
**摘要**：研究发现重组TSP50蛋白通过激活PAR2受体增强血管内皮生长因子(VEGF)的表达，促进血管生成。体内实验显示，沉默TSP50显著抑制肿瘤血管形成，揭示其在肿瘤微环境调控中的关键作用。
3. **文献名称**：*Development of a TSP50-Specific Monoclonal Antibody for Early Cancer Diagnosis*
**作者**：Wang, H. et al. (2019)
**摘要**：团队利用重组TSP50蛋白制备高亲和力单克隆抗体，验证其在结直肠癌患者血清和组织样本中的高特异性。临床数据分析表明，TSP50表达水平与肿瘤分期正相关，可能作为早期诊断标志物。
4. **文献名称**：*Structural Insights into the Catalytic Mechanism of TSP50 Through Cryo-EM Analysis*
**作者**：Kim, J. et al. (2021)
**摘要**：通过冷冻电镜解析TSP50蛋白的三维结构，揭示其活性位点关键氨基酸残基(如His-57和Ser-195)的空间构象，为设计靶向抑制剂提供结构基础。
---
如需具体文献，建议通过PubMed、Web of Science等平台以关键词“TSP50”、“Testisin”、“PRSS21”或“serine protease cancer”检索近期研究。
Recombinant human TSP50 (Testes-specific protease 50) protein is a genetically engineered version of the naturally occurring TSP50 enzyme, also known as PRSS50 or TESSPA. Originally identified as a testes-specific protein, TSP50 is expressed predominantly in germ cells and plays a critical role in spermatogenesis. However, aberrant overexpression of TSP50 has been observed in multiple cancers, including breast, colorectal, and gastric cancers, linking it to tumorigenesis and cancer progression.
Structurally, TSP50 belongs to the serine protease family, characterized by a conserved catalytic triad (His, Asp, Ser). Its recombinant form is typically produced in bacterial or mammalian expression systems, enabling studies of its biochemical properties and interaction networks. Despite sequence homology to proteases, recombinant TSP50 exhibits altered or reduced enzymatic activity compared to native forms, suggesting potential non-proteolytic functions in pathological conditions.
Functionally, TSP50 is implicated in regulating cell proliferation, apoptosis evasion, and metastasis through pathways such as Wnt/β-catenin and NF-κB signaling. Its overexpression correlates with poor clinical outcomes, making it a potential diagnostic biomarker and therapeutic target. Recent studies explore its role in modulating immune responses and chemotherapy resistance. Ongoing research aims to unravel its precise molecular mechanisms and evaluate the efficacy of TSP50-targeted therapies in preclinical models.
×
